Pres, Innovation, Tech Aubrey Rankin sold $859K of Revance Therapeutics, Inc.

Sold$859,438

$25.95Price

33,119Shares

−5%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, Feb 1. Filed Wed, Feb 3, 3:13 PM ET, during the session. Not investment advice.